Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Phase2 Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection

NCT04888949 is registered in ClinicalTrials.gov with Rohto Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT04888949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04888949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Phase2 Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection
Lead sponsor
Rohto Pharmaceutical Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
June 15, 2021
Completion date
May 18, 2023
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2 infection( covid-19 )